In UK, dating apps push vaccine drive | Inquirer Technology

In UK, dating apps push vaccine drive

/ 05:32 AM June 08, 2021

LONDON—Popular dating apps on Monday launched a campaign encouraging British users to post “I got my shot” on their profiles as the United Kingdom rollout reaches young adults.

In partnership with the government, apps including Tinder, Bumble and Hinge are offering special stickers, badges and bonuses for users who say they have had the coronavirus jab, the Department of Health said.

This comes as the UK rollout this week reaches the under-30s, as Health Secretary Matt Hancock confirmed on Sunday.

ADVERTISEMENT

Vaccines minister Nadhim Zahawi said he was “thrilled that we are partnering up with dating apps to boost vaccine uptake across the country.”

FEATURED STORIES

The United States launched a similar initiative in May, linking up with apps including Tinder, OkCupid and Plenty of Fish.

Credits, bonuses

In the UK, dating app users can show their support for vaccination on their profiles in return for complimentary credits or give in-app bonuses to others who say they are vaccinated.

Users of Plenty of Fish can post a badge saying “I got my shot” while OkCupid users can add a badge saying: “I’m vaccinated.”

The apps are also advertising the British government’s “Every vaccination gives us hope” campaign.

The health department even suggested that users could boost their romantic chances by telling potential dates they are vaccinated.

It cited a YouGov poll in May that found 28 percent of adults would not date someone who was unvaccinated and 31 percent would prefer not to.

ADVERTISEMENT

Caution

Despite turning to dating sites for help, the UK government has not formally given the green light to casual dating during the pandemic. The advice for England is that people can choose not to socially distance while meeting friends and family but should be “cautious.”

So far, the UK has given more than 27 million people both vaccine doses and more than 40 million have received a single dose.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Those under 40 are being offered an alternative to the Oxford-AstraZeneca vaccine due to a slightly higher risk of blood clots.

TOPICS:
TAGS:

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.